Prof. Oleh Taratula

Oregon State University, USA

Email: [email protected]

Qualifications

2003 Ph.D., The State University of New Jersey, Chemistry

1997 M.Sc., Ivan Franko National University of Lviv, Chemistry

Publications (selected)

1. Goo, Y. T., Grigoriev, V., Korzun, T., et al. (2026). Endogenous targeting lipid nanoparticles for systemic mRNA delivery to lung cancer tumors. Journal of Controlled Release, 394, Article 114870.
2. Singh, P., Raitmayr, C., Rizvi, S. Z. H., et al. (2026). Resonance Energy Transfer-Driven Photothermal Nanoagent Enables Melanoma Ablation Under Low-Power Near-Infrared Irradiation. Advanced Functional Materials, 36(36).
3. Wang, C., Sharma, K. S., Goo, Y. T., et al. (2026). Structurally Engineered Ferrous Metal-Organic Framework as a Chemodynamic Therapy Nanoagent for Concurrent Hydroxyl Radical and Singlet Oxygen Generation. Advanced Functional Materials, 36(35).
4. Korzun, T., Grigoriev, V., Goo, Y. T., et al. (2025). Follistatin mRNA-Loaded Lipid Nanoparticles Target Activin A-Expressing Metastatic Ovarian Cancer and Associated Cachexia. Obstetrics and Gynecology, 145(6S), 1644.
5. Halamish, H., Guo, Y. F., Finan, J. M., et al. (2025). KRAS inhibition targets and depends on pro-oncogenic HuR in PDAC. Cancer Research, 85(8), 5511.
6. Goo, Y. T., Grigoriev, V., Korzun, T., et al. (2025). Blood-Brain Barrier-Penetrating Nanocarriers Enable Microglial-Specific Drug Delivery in Hypothalamic Neuroinflammation. Advanced Healthcare Materials, 14(13), Article 2500521.
7. Singh, P., Duraisamy, K., Raitmayr, C., et al. (2025). Precision-Engineered Cobalt-Doped Iron Oxide Nanoparticles: From Octahedron Seeds to Cubical Bipyramids for Enhanced Magnetic Hyperthermia. Advanced Functional Materials, 35(33), Article 2414719.
8. Grigoriev, V., Korzun, T., Moses, AS., et al. (2024). Targeting Metastasis in Head and Neck Squamous Cell Carcinoma Using Follistatin mRNA Lipid Nanoparticles. ACS Nano, 18(49), 33330–33347.
9. Korzun, T., Moses, AS., Jozic, A., et al. (2024). Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 Axis. ACS Nano, 18(36), 24842–24859.
10. Minko, T., & Taratula, O. (2024). Nanomedicine for Women's Health. Small, 20(41).
11. Slayden, O., Luo, F. Z., Park, Y., et al. (2024). Targeted nanoparticles for imaging and therapy of endometriosis. Biology of Reproduction, 110(6), 1191–1200.
12. Taratula, O., Korzun, T., Jozic, A., et al. (2024). Comprehensive therapeutic impact: Follistatin mRNA-loaded lipid nanoparticles halt lung metastases and prolong survival in murine head & neck squamous cell carcinoma. Cancer Research, 84(7), LB019.
13. Slayden, O. D., Luo, F. Z., Wilson, R. C., et al. (2023). ADVANCES IN ENDOMETRIOSIS THERAPY: UPTAKE OF SYSTEMICALLY DELIVERED MAGNETIC NANOPARTICLES BY SPONTANEOUS ENDOMETRIOTIC LESIONS IN RHESUS MACAQUES. Fertility and Sterility, 120(4), E190–E191.
14. Park, Y., Korzun, T., Moses, AS., et al. (2024). Targeted Nanocarriers for Systemic Delivery of IRAK4 Inhibitors to Inflamed Tissues. Small, 20(4).
15. Korzun, T., Moses, AS., Diba, P., et al. (2023). From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics. Pharmaceuticals, 16(8), Article 1088.
16. Korzun, T., Moses, AS. S., Diba, P., et al. (2024). Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers. Small, 20(41).
17. Mamnoon, B., Moses, AS., Sundaram, S., et al. (2024). Glutathione-Responsive Methotrexate Polymersomes for Potential Management of Ectopic Pregnancy. Small, 20(41).
18. Herrera-Barrera, M., Ryals, R. C., Gautam, M., et al. (2023). Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates. Science Advances, 9(2), Article eadd4623.
19. Taratula, O., & Taratula, O. R. (2023). Novel Nanoparticle-Based Treatment and Imaging Modalities. Pharmaceutics, 15(1), Article 244.
20. St Lorenz, A., Moses, AS., Mamnoon, B., et al. (2023). A Photoacoustic Contrast Nanoagent with a Distinct Spectral Signature for Ovarian Cancer Management. Advanced Healthcare Materials, 12(9).

Profile Details
https://pharmacy.oregonstate.edu/faculty-staff/directory/oleh-taratula
https://scholar.google.com/citations?user=X0QlD4kAAAAJ&hl=en
https://www.researchgate.net/profile/Oleh-Taratula

WOS ResearcherID: CBY-6806-2022